Comparison of three different methods for radiolabelling human activated T lymphocytes

Carlo Botti, Donatella R M Negri, Ettore Seregni, Venkatesh Ramakrishna, Flavio Arienti, Lorenzo Maffioli, Claudia Lombardo, Anna Bogni, Claudio Pascali, Flavio Crippa, Simonetta Massaron, Federica Remonti, Silvia Nerini-Molteni, Silvana Canevari, Emilio Bombardieri

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

One approach in the treatment of ovarian cancer patients involves the infusion of autologous T lymphocytes coupled with a bispecific monoclonal antibody MOv18/anti-CD3 (biMAb OC/TR), which recognizes a 38-kDa glycoprotein expressed on ovarian carcinomas and the CD3 T cell receptor. However, little is known about the in vivo biodistribution of injected activated lymphocytes, information that could be obtained by scintigraphic imaging of radiolabelled T cells in order to visualize the migratory pattern. We compared the efficiency, stability and toxicity of technetium-99m hexamethylpropylene amine oxime (HMPAO), indium-111 oxine and fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) in radiolabelling activated lymphocytes targeted with biMAb OC/TR. The mean labelling efficiencies of 111In-oxine and 18F-FDG using 2.5 x 108 lymphocytes (68% and 64%, respectively) were more than twice that of 99mTc-HMPAO (31%). Retention of the radionuclide in the cell was highest in the case of 111In-oxine labelling (less than 25% of the initial cell-bound activity released after 240 min, as compared with 44% of the 99mTc label in the same period and 45% of 18F radionuclide released after 150 min). None of the three radiolabelling reagents induced any significant alteration in cell viability or immunophenotype. However, both 111In-oxine and 18F-FDG induced a loss of cytotoxic activity of lymphocytes against the ovarian carcinoma cell line IG-ROV1, and all three radiolabelling reagents caused a significant reduction in the proliferative ability of labelled lymphocytes compared to controls, with cell death occurring after 8-9 days. Radiolabelling with the more stable 111In-oxine reagent using a higher number of lymphocytes (1.4 x 109) but the same total activity (around 55.5 MBq) resulted in improved labelled T cell viability and proliferative ability, although the mean labelling efficiency decreased (35.8%). Together the data suggest that 111In-oxine at low activity per cell is the most appropriate reagent for radiolabelling activated retargeted T lymphocytes useful for in vivo biodistribution studies.

Original languageEnglish
Pages (from-to)497-504
Number of pages8
JournalEuropean Journal Of Nuclear Medicine
Volume24
Issue number5
DOIs
Publication statusPublished - 1997

Fingerprint

T-Lymphocytes
Lymphocytes
Fluorodeoxyglucose F18
Oximes
Radioisotopes
Amines
Cell Survival
Bispecific Antibodies
Carcinoma
Fluorine
Technetium
Lymphocyte Count
T-Cell Antigen Receptor
Ovarian Neoplasms
indium oxine
Glycoproteins
Cell Death
Cell Line
OC-TR monoclonal antibody
Therapeutics

Keywords

  • Adoptive immunotherapy
  • Bispecific monoclonal antibody
  • Fluorine-18 2-fluoro-2-deoxy-D-glucose
  • Indium-111 oxine
  • Lymphocyte radiolabelling
  • Ovarian cancer
  • Technetium hexamethylpropylene amine oxime

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Comparison of three different methods for radiolabelling human activated T lymphocytes. / Botti, Carlo; Negri, Donatella R M; Seregni, Ettore; Ramakrishna, Venkatesh; Arienti, Flavio; Maffioli, Lorenzo; Lombardo, Claudia; Bogni, Anna; Pascali, Claudio; Crippa, Flavio; Massaron, Simonetta; Remonti, Federica; Nerini-Molteni, Silvia; Canevari, Silvana; Bombardieri, Emilio.

In: European Journal Of Nuclear Medicine, Vol. 24, No. 5, 1997, p. 497-504.

Research output: Contribution to journalArticle

Botti, C, Negri, DRM, Seregni, E, Ramakrishna, V, Arienti, F, Maffioli, L, Lombardo, C, Bogni, A, Pascali, C, Crippa, F, Massaron, S, Remonti, F, Nerini-Molteni, S, Canevari, S & Bombardieri, E 1997, 'Comparison of three different methods for radiolabelling human activated T lymphocytes', European Journal Of Nuclear Medicine, vol. 24, no. 5, pp. 497-504. https://doi.org/10.1007/s002590050081
Botti, Carlo ; Negri, Donatella R M ; Seregni, Ettore ; Ramakrishna, Venkatesh ; Arienti, Flavio ; Maffioli, Lorenzo ; Lombardo, Claudia ; Bogni, Anna ; Pascali, Claudio ; Crippa, Flavio ; Massaron, Simonetta ; Remonti, Federica ; Nerini-Molteni, Silvia ; Canevari, Silvana ; Bombardieri, Emilio. / Comparison of three different methods for radiolabelling human activated T lymphocytes. In: European Journal Of Nuclear Medicine. 1997 ; Vol. 24, No. 5. pp. 497-504.
@article{cfb99f7857a54339b4bc1036f237bfeb,
title = "Comparison of three different methods for radiolabelling human activated T lymphocytes",
abstract = "One approach in the treatment of ovarian cancer patients involves the infusion of autologous T lymphocytes coupled with a bispecific monoclonal antibody MOv18/anti-CD3 (biMAb OC/TR), which recognizes a 38-kDa glycoprotein expressed on ovarian carcinomas and the CD3 T cell receptor. However, little is known about the in vivo biodistribution of injected activated lymphocytes, information that could be obtained by scintigraphic imaging of radiolabelled T cells in order to visualize the migratory pattern. We compared the efficiency, stability and toxicity of technetium-99m hexamethylpropylene amine oxime (HMPAO), indium-111 oxine and fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) in radiolabelling activated lymphocytes targeted with biMAb OC/TR. The mean labelling efficiencies of 111In-oxine and 18F-FDG using 2.5 x 108 lymphocytes (68{\%} and 64{\%}, respectively) were more than twice that of 99mTc-HMPAO (31{\%}). Retention of the radionuclide in the cell was highest in the case of 111In-oxine labelling (less than 25{\%} of the initial cell-bound activity released after 240 min, as compared with 44{\%} of the 99mTc label in the same period and 45{\%} of 18F radionuclide released after 150 min). None of the three radiolabelling reagents induced any significant alteration in cell viability or immunophenotype. However, both 111In-oxine and 18F-FDG induced a loss of cytotoxic activity of lymphocytes against the ovarian carcinoma cell line IG-ROV1, and all three radiolabelling reagents caused a significant reduction in the proliferative ability of labelled lymphocytes compared to controls, with cell death occurring after 8-9 days. Radiolabelling with the more stable 111In-oxine reagent using a higher number of lymphocytes (1.4 x 109) but the same total activity (around 55.5 MBq) resulted in improved labelled T cell viability and proliferative ability, although the mean labelling efficiency decreased (35.8{\%}). Together the data suggest that 111In-oxine at low activity per cell is the most appropriate reagent for radiolabelling activated retargeted T lymphocytes useful for in vivo biodistribution studies.",
keywords = "Adoptive immunotherapy, Bispecific monoclonal antibody, Fluorine-18 2-fluoro-2-deoxy-D-glucose, Indium-111 oxine, Lymphocyte radiolabelling, Ovarian cancer, Technetium hexamethylpropylene amine oxime",
author = "Carlo Botti and Negri, {Donatella R M} and Ettore Seregni and Venkatesh Ramakrishna and Flavio Arienti and Lorenzo Maffioli and Claudia Lombardo and Anna Bogni and Claudio Pascali and Flavio Crippa and Simonetta Massaron and Federica Remonti and Silvia Nerini-Molteni and Silvana Canevari and Emilio Bombardieri",
year = "1997",
doi = "10.1007/s002590050081",
language = "English",
volume = "24",
pages = "497--504",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Berlin Heidelberg",
number = "5",

}

TY - JOUR

T1 - Comparison of three different methods for radiolabelling human activated T lymphocytes

AU - Botti, Carlo

AU - Negri, Donatella R M

AU - Seregni, Ettore

AU - Ramakrishna, Venkatesh

AU - Arienti, Flavio

AU - Maffioli, Lorenzo

AU - Lombardo, Claudia

AU - Bogni, Anna

AU - Pascali, Claudio

AU - Crippa, Flavio

AU - Massaron, Simonetta

AU - Remonti, Federica

AU - Nerini-Molteni, Silvia

AU - Canevari, Silvana

AU - Bombardieri, Emilio

PY - 1997

Y1 - 1997

N2 - One approach in the treatment of ovarian cancer patients involves the infusion of autologous T lymphocytes coupled with a bispecific monoclonal antibody MOv18/anti-CD3 (biMAb OC/TR), which recognizes a 38-kDa glycoprotein expressed on ovarian carcinomas and the CD3 T cell receptor. However, little is known about the in vivo biodistribution of injected activated lymphocytes, information that could be obtained by scintigraphic imaging of radiolabelled T cells in order to visualize the migratory pattern. We compared the efficiency, stability and toxicity of technetium-99m hexamethylpropylene amine oxime (HMPAO), indium-111 oxine and fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) in radiolabelling activated lymphocytes targeted with biMAb OC/TR. The mean labelling efficiencies of 111In-oxine and 18F-FDG using 2.5 x 108 lymphocytes (68% and 64%, respectively) were more than twice that of 99mTc-HMPAO (31%). Retention of the radionuclide in the cell was highest in the case of 111In-oxine labelling (less than 25% of the initial cell-bound activity released after 240 min, as compared with 44% of the 99mTc label in the same period and 45% of 18F radionuclide released after 150 min). None of the three radiolabelling reagents induced any significant alteration in cell viability or immunophenotype. However, both 111In-oxine and 18F-FDG induced a loss of cytotoxic activity of lymphocytes against the ovarian carcinoma cell line IG-ROV1, and all three radiolabelling reagents caused a significant reduction in the proliferative ability of labelled lymphocytes compared to controls, with cell death occurring after 8-9 days. Radiolabelling with the more stable 111In-oxine reagent using a higher number of lymphocytes (1.4 x 109) but the same total activity (around 55.5 MBq) resulted in improved labelled T cell viability and proliferative ability, although the mean labelling efficiency decreased (35.8%). Together the data suggest that 111In-oxine at low activity per cell is the most appropriate reagent for radiolabelling activated retargeted T lymphocytes useful for in vivo biodistribution studies.

AB - One approach in the treatment of ovarian cancer patients involves the infusion of autologous T lymphocytes coupled with a bispecific monoclonal antibody MOv18/anti-CD3 (biMAb OC/TR), which recognizes a 38-kDa glycoprotein expressed on ovarian carcinomas and the CD3 T cell receptor. However, little is known about the in vivo biodistribution of injected activated lymphocytes, information that could be obtained by scintigraphic imaging of radiolabelled T cells in order to visualize the migratory pattern. We compared the efficiency, stability and toxicity of technetium-99m hexamethylpropylene amine oxime (HMPAO), indium-111 oxine and fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) in radiolabelling activated lymphocytes targeted with biMAb OC/TR. The mean labelling efficiencies of 111In-oxine and 18F-FDG using 2.5 x 108 lymphocytes (68% and 64%, respectively) were more than twice that of 99mTc-HMPAO (31%). Retention of the radionuclide in the cell was highest in the case of 111In-oxine labelling (less than 25% of the initial cell-bound activity released after 240 min, as compared with 44% of the 99mTc label in the same period and 45% of 18F radionuclide released after 150 min). None of the three radiolabelling reagents induced any significant alteration in cell viability or immunophenotype. However, both 111In-oxine and 18F-FDG induced a loss of cytotoxic activity of lymphocytes against the ovarian carcinoma cell line IG-ROV1, and all three radiolabelling reagents caused a significant reduction in the proliferative ability of labelled lymphocytes compared to controls, with cell death occurring after 8-9 days. Radiolabelling with the more stable 111In-oxine reagent using a higher number of lymphocytes (1.4 x 109) but the same total activity (around 55.5 MBq) resulted in improved labelled T cell viability and proliferative ability, although the mean labelling efficiency decreased (35.8%). Together the data suggest that 111In-oxine at low activity per cell is the most appropriate reagent for radiolabelling activated retargeted T lymphocytes useful for in vivo biodistribution studies.

KW - Adoptive immunotherapy

KW - Bispecific monoclonal antibody

KW - Fluorine-18 2-fluoro-2-deoxy-D-glucose

KW - Indium-111 oxine

KW - Lymphocyte radiolabelling

KW - Ovarian cancer

KW - Technetium hexamethylpropylene amine oxime

UR - http://www.scopus.com/inward/record.url?scp=8244255923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8244255923&partnerID=8YFLogxK

U2 - 10.1007/s002590050081

DO - 10.1007/s002590050081

M3 - Article

VL - 24

SP - 497

EP - 504

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 5

ER -